Cascade Therapeutics Inc. is a privately held biopharmaceutical company engaged in the discovery and development of breakthrough medical therapies to improve the lives of people suffering from disorders and diseases that are mediated through the central nervous system. Cascade’s initial focus is on the development of novel therapeutics for the treatment of epilepsy, obesity and neuropathic pain. Cascade has a strong portfolio of distinct product candidates with attractive therapeutic profiles, and is well positioned to achieve its objectives.
P: 416.673.8199
Website:
www.cascadetherapeutics.com
